News

3 min read

SmartCella enters agreement to advance Professor Johan Ericson’s research on cell replacement therapies for Parkinson’s disease

Read Story
3 min read

SmartCella tecknar avtal för vidareutveckling av professor Johan Ericsons forskning kring stamcellbaserad behandling av Parkinsons sjukdom

Read Story
2 min read

SmartCella granted new European patent for the Extroducer delivery platform

Read Story
6 min read

XyloCor Therapeutics and SmartCella Enter into License Agreement for Use of the Extroducer Infusion Catheter System to Administer Novel Gene Therapy XC001 to the Heart

Read Story
4 min read

SmartCella raises EUR 50 million to accelerate growth and commercialization

Read Story
4 min read

Senior life science and medical specialists join SmartCella’s Board of Directors

Read Story
4 min read

SmartCella strengthens team with Dr. Ricardo Baptista as CTO

Read Story
5 min read

CEO comments on the full year of 2023

Read Story
4 min read

SmartCella AB appoints Oskar Steneryd as new CFO

Read Story
3 min read

SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies

Read Story

Let’s pioneer the future of targeted therapies together